Arginylated Calreticulin Increases Apoptotic Response Induced by Bortezomib in Glioma Cells

COMBA, ANDREA; BONNET, LAURA V.; GOITEA, VICTOR E.; HALLAK, MARTA E.; GALIANO, MAURICIO R.

MOLECULAR NEUROBIOLOGY

HUMANA PRESS INC

Año: 2018 vol. 55

0893-7648

fter retrotranslocation from the endoplasmic reticulum to the cytoplasm, calreticulin is modified by the enzyme arginyltransferase-1(ATE1). Cellular levels of arginylated calreticulin (R-CRT) are regulated in part by the proteasomal system. Under various stressconditions, R-CRT becomes associated with stress granules (SGs) or reaches the plasma membrane (PM), where it participates in pro-apoptotic signaling. The mechanisms underlying the resistance of tumor cells to apoptosis induced by specific drugs remain unclear.We evaluated the regulatory role of R-CRT in apoptosis of human glioma cell lines treated with the proteasome inhibitor bortezomib(BT). Two cell lines (HOG, MO59K) displaying distinctive susceptibility to apoptosis induction were studied further. BT efficiencywas found to be correlated with a subcellular distribution of R-CRT. In MO59K (apoptosis-resistant), R-CRT was confined to SGsformed following BT treatment. In contrast, HOG (apoptosis-susceptible) treated with BT sho